Noreen Scherer
Chief Tech/Sci/R&D Officer at LARIMAR THERAPEUTICS, INC.
Profile
Noreen Scherer is currently the Vice President-Clinical Operations at Larimar Therapeutics, Inc. and Alcobra, Inc. She previously held the same position at Chondrial Therapeutics, Inc. Ms. Scherer completed her undergraduate degree at LaSalle University.
Noreen Scherer active positions
| Companies | Position | Start |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2018 |
| Alcobra, Inc. | Chief Operating Officer | - |
Former positions of Noreen Scherer
| Companies | Position | End |
|---|---|---|
Chondrial Therapeutics, Inc.
 Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA. | Chief Tech/Sci/R&D Officer | - |
Training of Noreen Scherer
| LaSalle University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LARIMAR THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Chondrial Therapeutics, Inc.
Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA. | Health Technology |
| Alcobra, Inc. |
- Stock Market
- Insiders
- Noreen Scherer